Home
>
National Drug Code (NDC)
>
BLEPHAMIDE
BLEPHAMIDE - 0023-0313-04 - (sulfacetamide sodium and prednisolone acetate)
Drug Information of BLEPHAMIDE
| Product NDC: | 0023-0313 |
| Proprietary Name: | BLEPHAMIDE |
| Non Proprietary Name: | sulfacetamide sodium and prednisolone acetate |
| Active Ingredient(s): | 2; 100 mg/g; mg/g & nbsp; sulfacetamide sodium and prednisolone acetate |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BLEPHAMIDE
| Product NDC: | 0023-0313 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA087748 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19870101 |
Package Information of BLEPHAMIDE
| Package NDC: | 0023-0313-04 |
| Package Description: | 1 TUBE in 1 CARTON (0023-0313-04) > 3.5 g in 1 TUBE |
NDC Information of BLEPHAMIDE
| NDC Code | 0023-0313-04 |
| Proprietary Name | BLEPHAMIDE |
| Package Description | 1 TUBE in 1 CARTON (0023-0313-04) > 3.5 g in 1 TUBE |
| Product NDC | 0023-0313 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sulfacetamide sodium and prednisolone acetate |
| Dosage Form Name | OINTMENT |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19870101 |
| Marketing Category Name | ANDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM |
| Strength Number | 2; 100 |
| Strength Unit | mg/g; mg/g |
| Pharmaceutical Classes | Sulfonamide Antibacterial [EPC],Sulfonamides [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
